AZB & Partners Advises Sequent Scientific on Merger with Viyash Life Sciences

Published on Dec 13, 2024

AZB & Partners advised Sequent Scientific Limited on the proposed acquisition of Viyash Life Sciences Private Limited and its subsidiaries by way of an approx. INR 8,000 crore merger. Our deal team comprised our Senior Partners Ashwath Rau and Kashish Bhatia, Counsel Himanshoo Tembe, Senior Associates A. Robin Singh and Dishti Kaji, Associates Yashi Saraswat and Meghna Somani.